Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Conditions: Cryptogenic Stroke
Sponsors: The Cooper Health System; Duke University; Covenant Health; University of Colorado, Denver; Medical University of South Carolina; University of Maryland, Baltimore; University of Pennsylvania; Emory University; University of Chicago; University of Tennessee; Ohio State University; West Virginia University; Mayo Clinic; Boston Medical Center; Rhode Island Hospital; Beth Israel Lahey Health; Christiana Care Health Services; Henry Ford Health System; Thomas Jefferson University; University of Iowa; University of California, Los Angeles; Allina Health System; Yale University; The University of Texas Health Science Center, Houston; Dartmouth-Hitchcock Medical Center; Virginia Commonwealth University
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 4, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments